Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New hope to stop liver Cancer's return after surgery
Disease control Recruiting nowThis study is testing if adding a procedure called TACE after curative liver cancer surgery helps prevent the cancer from coming back. It will involve 442 patients who have had surgery but are at high risk of recurrence. Patients will be randomly assigned to either receive the TA…
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Massive data dive aims to find best liver cancer treatment paths
Knowledge-focused Recruiting nowThis study is looking back at the medical records of 2000 people in China with liver cancer (hepatocellular carcinoma) who received treatments to try to shrink their tumors before possible surgery. The goal is to figure out which combinations of drugs and procedures work best for…
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:52 UTC